Ozempic and Wegovy Lawsuits

Which drugs the cases name

The cases name eight drugs, made by two companies.

• Novo Nordisk makes Ozempic, Wegovy, Rybelsus, Saxenda and Victoza.
• Eli Lilly makes Mounjaro, Zepbound and Trulicity.

Most of them are shots. Ozempic, Wegovy, Mounjaro, Zepbound and Trulicity are taken once a week. Saxenda and Victoza are taken once a day. Rybelsus is a pill you swallow once a day. It holds semaglutide, the same medicine that is in Ozempic and Wegovy.

All eight work the same basic way. They slow down how fast your stomach empties, which is part of why you feel full. The lawsuits say that for some people the stomach slowed too much and stayed that way, even after they stopped taking the drug. Ozempic, Wegovy and Mounjaro come up most often in the filings.

Brand-name drugs and compounded versions

While the brand-name drugs were hard to find, many people got a compounded version instead. A compounding pharmacy mixes its own copy of the medicine, usually semaglutide or tirzepatide. People often bought these through an online weight loss clinic or a med spa. The FDA does not approve compounded drugs.

The federal cases are against Novo Nordisk and Eli Lilly. They are about the drugs those two companies make and the warnings those companies put on their labels. That makes the brand name on your prescription one of the first things a lawyer looks at.

Your pharmacy label can tell you which one you had. A brand-name fill names the brand, such as Ozempic or Zepbound. A compounded fill usually names only the medicine and comes from a compounding pharmacy. It often arrives as a small glass vial that you draw from with a syringe, in place of a prefilled pen.

Some people switched between the two. If you did, the dates of each fill matter. If you took a compounded version, whether you have any claim depends on the facts, including who made it and who sold it to you.

The health problems people report

Four kinds of harm come up most often in the stomach cases.

• Gastroparesis. Some doctors call it stomach paralysis. The stomach muscles stop pushing food along. People feel sick, throw up, hurt, and cannot eat normally.
• Ileus. The intestines stop moving and nothing passes through. This one can turn into an emergency.
• Bowel blockage. Something gets stuck and food cannot get past it.
• Gallbladder trouble. Stones, swelling, or surgery to remove the gallbladder.

The eye cases are separate. People describe the sight in one eye going dim or dark over about a day. Doctors call it NAION. It usually does not come back. Our guide to Ozempic and vision loss lawsuits explains how eye doctors confirm it and which records matter.

Where the cases stand

The federal cases are sorted into two groups, both in front of the same judge in Philadelphia. Grouping cases this way is normal when many people sue over the same product. One judge handles the parts that are the same for everyone, like collecting company records. Each person still has their own case.

• Stomach cases. 4,025 as of October 1, 2026. Two years earlier the number was closer to 1,000.
• Eye cases. 247 as of that same date. That group was created in December 2025.

Through most of 2026, new stomach cases arrived at roughly 80 to 90 a month. In September only 3 were added. The eye cases grew by 31 over the same month.

The test that matters for stomach claims

In August 2025 the judge ruled that anyone claiming stomach paralysis has to back it up with a properly performed gastric emptying study. That test measures how long food actually takes to leave your stomach. The court accepts three kinds. One is a scan after you eat food containing a small, safe marker. Another is a breath test. The third is a capsule you swallow that sends readings as it travels.

This ruling matters because most of the stomach cases rest on that diagnosis. Plenty of people were told they had gastroparesis based on symptoms alone and never had any of these tests. If you had one, the result is worth getting a copy of. How much it matters for any one person depends on what their records actually show, which is the kind of thing a lawyer reviews case by case.

Bowel blockage is proven a different way. Doctors usually confirm a blockage with imaging, such as a CT scan or an X-ray, often in the emergency room. If you were treated for one, ask for the imaging report along with the hospital records.

What happens next

The judge is working through a big question right now. She has to decide whether the expert doctors and scientists hired by the injured people are allowed to testify about warnings and about what causes these injuries. She held a hearing on it in Philadelphia over five days, September 14 through 18, 2026.

That decision shapes everything after it. If those experts are allowed in, the cases move toward trials. If they are kept out, many of these cases could end. The judge has not ruled yet and there is no set date for it.

She has already ruled against the injured people once on a question like this. Her August 2025 order required a gastric emptying study. The same order barred two of their experts from testifying on how gastroparesis is diagnosed, while the drug companies' expert was allowed to testify.

Some things have not happened yet, and it is worth being plain about them. Nobody has been paid. There is no settlement and no fund. No case has gone in front of a jury, and no trial date has been set. Anyone promising a payout from these cases today is describing something that does not exist.

For the latest court activity, including the schedule for the vision loss cases, see the Ozempic lawsuit updates page. That page is rewritten each time something changes in court.

What to keep

Whatever happens in court, a few records are worth holding onto.

• Pharmacy printouts showing the drug name, the pharmacy, and every date you filled it.
• The name of each doctor who prescribed it. If you switched drugs, note which doctor prescribed which one.
• The box or pharmacy label from your pens or pills. Used needles belong in a sharps container, so there is no need to keep them.
• Hospital or emergency room paperwork, if you have any.
• A copy of any test result, especially a gastric emptying study or an imaging report.
• A note of roughly when you started, when you took your last dose, and when symptoms started.

Deadlines for filing are set by each state, and they keep running whether or not anything is happening in court. You can read more about how filing deadlines work, how mass torts work, or what evidence helps a lawsuit. If you want the research behind all of this, see does Ozempic cause gastroparesis.

Frequently Asked Questions

Is there a settlement yet?

No. No money has been paid, there is no settlement fund, and there is no claim form to fill out. The cases are still at the stage where lawyers argue in front of a judge about what evidence a jury would be allowed to hear.

Which drugs are named in these cases?

Novo Nordisk makes Ozempic, Wegovy, Rybelsus, Saxenda and Victoza. Eli Lilly makes Mounjaro, Zepbound and Trulicity. Rybelsus is a daily pill and the rest are shots. Ozempic, Wegovy and Mounjaro come up most often.

What if I took a compounded version?

The federal cases are against Novo Nordisk and Eli Lilly over the brand-name drugs they make. A compounded version is mixed by a compounding pharmacy. Whether someone who took one has any claim depends on the facts, including who made it and who sold it.

What is NAION?

NAION is sudden vision loss in one eye. Blood flow to the nerve behind the eye drops and sight in that eye fades fast, often within a day. It is usually permanent. Eye cases are handled separately from the stomach cases.

Should I stop taking my shot?

That is a question for your prescribing doctor, not for a web page and not for a lawyer. Stopping a diabetes or weight medicine on your own can cause its own problems. Bring your concerns to the person who prescribed it.

How long do cases like this usually take?

Years, not months. These cases were first grouped together in 2024 and no trial date has been set. Large drug cases often run five years or longer from beginning to end.

Sources

• Judicial Panel on Multidistrict Litigation, pending MDL report of October 1, 2026 (PDF) — the report the case counts on this page come from. It lists 4,025 actions in MDL 3094 and 247 in MDL 3163.
• Judicial Panel on Multidistrict Litigation, Pending MDLs — where a newer report is posted on the first business day of each month, if you want to check the current numbers yourself.
• Eastern District of Pennsylvania, official page for MDL 3094 — the court’s own page for the stomach injury cases, which names the drugs in the case and the presiding judge.
• Eastern District of Pennsylvania, official page for MDL 3163 — the court’s page for the NAION vision loss cases, which were separated from the stomach cases.
• Eastern District of Pennsylvania, orders in MDL 3094 — every order the judge has entered in the stomach cases. The gastric emptying study requirement is the memorandum order at ECF No. 468, signed August 15, 2025, which accepts scintigraphy, a breath test, or a wireless motility capsule.
• Scheduling order for the Rule 702 hearing, entered August 28, 2026 (PDF) — moved the hearing on the expert testimony to September 14 through 18, 2026.
• Court docket, In re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, MDL No. 3094, No. 2:24-md-03094-KSM (E.D. Pa.) — the case record itself, which is where the order numbers, hearing dates and case counts above were checked. It is available through PACER.

Figures and dates above should be confirmed against the original sources.